For Australians at high risk of developing severe COVID-19, getting access to potentially lifesaving treatment recently became easier — but experts say some are still missing out.
On May 1, COVID-19 antiviral drug Paxlovid — the most effective oral treatment to date — was listed on the Pharmaceutical Benefits Scheme (PBS), which means it can now be prescribed by a GP or nurse and dispensed at a community pharmacy.
